Global Pharmacovigilance (PV) Market Size, Status and Forecast 2019-2025

  • receipt Report ID : 184404
  • calendar_today Published On: Jan, 2020
  • file_copy Pages: 150
  • list Business Services

In 2018, the global Pharmacovigilance (PV) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Pharmacovigilance (PV) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacovigilance (PV) development in United States, Europe and China.

The key players covered in this study

Accenture

Clinquest Group B.V.

Cognizant

Laboratory Corporation of America Holdings

IBM Corporation

ArisGlobal

ICON plc.

Capgemini

ITClinical

iMEDGlobal

Foresight Group International AG

TAKE Solutions Ltd.

PAREXEL International Corporation

BioClinica

Wipro Ltd.

United BioSource Corporation

Market segment by Type, the product can be split into

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Market segment by Application, split into

Hospitals

Research Organizations

Industrial

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Pharmacovigilance (PV) status, future forecast, growth opportunity, key market and key players.

To present the Pharmacovigilance (PV) development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pharmacovigilance (PV) are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Pharmacovigilance (PV) Market Size Growth Rate by Type (2014-2025)

1.4.2 Spontaneous Reporting

1.4.3 Intensified ADR Reporting

1.4.4 Targeted Spontaneous Reporting

1.4.5 Cohort Event Monitoring

1.4.6 EHR Mining

1.5 Market by Application

1.5.1 Global Pharmacovigilance (PV) Market Share by Application (2014-2025)

1.5.2 Hospitals

1.5.3 Research Organizations

1.5.4 Industrial

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Pharmacovigilance (PV) Market Size

2.2 Pharmacovigilance (PV) Growth Trends by Regions

2.2.1 Pharmacovigilance (PV) Market Size by Regions (2014-2025)

2.2.2 Pharmacovigilance (PV) Market Share by Regions (2014-2019)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Pharmacovigilance (PV) Market Size by Manufacturers

3.1.1 Global Pharmacovigilance (PV) Revenue by Manufacturers (2014-2019)

3.1.2 Global Pharmacovigilance (PV) Revenue Market Share by Manufacturers (2014-2019)

3.1.3 Global Pharmacovigilance (PV) Market Concentration Ratio (CR5 and HHI)

3.2 Pharmacovigilance (PV) Key Players Head office and Area Served

3.3 Key Players Pharmacovigilance (PV) Product/Solution/Service

3.4 Date of Enter into Pharmacovigilance (PV) Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Pharmacovigilance (PV) Market Size by Type (2014-2019)

4.2 Global Pharmacovigilance (PV) Market Size by Application (2014-2019)

5 United States

5.1 United States Pharmacovigilance (PV) Market Size (2014-2019)

5.2 Pharmacovigilance (PV) Key Players in United States

5.3 United States Pharmacovigilance (PV) Market Size by Type

5.4 United States Pharmacovigilance (PV) Market Size by Application

6 Europe

6.1 Europe Pharmacovigilance (PV) Market Size (2014-2019)

6.2 Pharmacovigilance (PV) Key Players in Europe

6.3 Europe Pharmacovigilance (PV) Market Size by Type

6.4 Europe Pharmacovigilance (PV) Market Size by Application

7 China

7.1 China Pharmacovigilance (PV) Market Size (2014-2019)

7.2 Pharmacovigilance (PV) Key Players in China

7.3 China Pharmacovigilance (PV) Market Size by Type

7.4 China Pharmacovigilance (PV) Market Size by Application

8 Japan

8.1 Japan Pharmacovigilance (PV) Market Size (2014-2019)

8.2 Pharmacovigilance (PV) Key Players in Japan

8.3 Japan Pharmacovigilance (PV) Market Size by Type

8.4 Japan Pharmacovigilance (PV) Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Pharmacovigilance (PV) Market Size (2014-2019)

9.2 Pharmacovigilance (PV) Key Players in Southeast Asia

9.3 Southeast Asia Pharmacovigilance (PV) Market Size by Type

9.4 Southeast Asia Pharmacovigilance (PV) Market Size by Application

10 India

10.1 India Pharmacovigilance (PV) Market Size (2014-2019)

10.2 Pharmacovigilance (PV) Key Players in India

10.3 India Pharmacovigilance (PV) Market Size by Type

10.4 India Pharmacovigilance (PV) Market Size by Application

11 Central & South America

11.1 Central & South America Pharmacovigilance (PV) Market Size (2014-2019)

11.2 Pharmacovigilance (PV) Key Players in Central & South America

11.3 Central & South America Pharmacovigilance (PV) Market Size by Type

11.4 Central & South America Pharmacovigilance (PV) Market Size by Application

12 International Players Profiles

12.1 Accenture

12.1.1 Accenture Company Details

12.1.2 Company Description and Business Overview

12.1.3 Pharmacovigilance (PV) Introduction

12.1.4 Accenture Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.1.5 Accenture Recent Development

12.2 Clinquest Group B.V.

12.2.1 Clinquest Group B.V. Company Details

12.2.2 Company Description and Business Overview

12.2.3 Pharmacovigilance (PV) Introduction

12.2.4 Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.2.5 Clinquest Group B.V. Recent Development

12.3 Cognizant

12.3.1 Cognizant Company Details

12.3.2 Company Description and Business Overview

12.3.3 Pharmacovigilance (PV) Introduction

12.3.4 Cognizant Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.3.5 Cognizant Recent Development

12.4 Laboratory Corporation of America Holdings

12.4.1 Laboratory Corporation of America Holdings Company Details

12.4.2 Company Description and Business Overview

12.4.3 Pharmacovigilance (PV) Introduction

12.4.4 Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.4.5 Laboratory Corporation of America Holdings Recent Development

12.5 IBM Corporation

12.5.1 IBM Corporation Company Details

12.5.2 Company Description and Business Overview

12.5.3 Pharmacovigilance (PV) Introduction

12.5.4 IBM Corporation Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.5.5 IBM Corporation Recent Development

12.6 ArisGlobal

12.6.1 ArisGlobal Company Details

12.6.2 Company Description and Business Overview

12.6.3 Pharmacovigilance (PV) Introduction

12.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.6.5 ArisGlobal Recent Development

12.7 ICON plc.

12.7.1 ICON plc. Company Details

12.7.2 Company Description and Business Overview

12.7.3 Pharmacovigilance (PV) Introduction

12.7.4 ICON plc. Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.7.5 ICON plc. Recent Development

12.8 Capgemini

12.8.1 Capgemini Company Details

12.8.2 Company Description and Business Overview

12.8.3 Pharmacovigilance (PV) Introduction

12.8.4 Capgemini Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.8.5 Capgemini Recent Development

12.9 ITClinical

12.9.1 ITClinical Company Details

12.9.2 Company Description and Business Overview

12.9.3 Pharmacovigilance (PV) Introduction

12.9.4 ITClinical Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.9.5 ITClinical Recent Development

12.10 iMEDGlobal

12.10.1 iMEDGlobal Company Details

12.10.2 Company Description and Business Overview

12.10.3 Pharmacovigilance (PV) Introduction

12.10.4 iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2014-2019)

12.10.5 iMEDGlobal Recent Development

12.11 Foresight Group International AG

12.12 TAKE Solutions Ltd.

12.13 PAREXEL International Corporation

12.14 BioClinica

12.15 Wipro Ltd.

12.16 United BioSource Corporation

13 Market Forecast 2019-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2019-2025)

13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Pharmacovigilance (PV) Key Market Segments

Table Key Players Pharmacovigilance (PV) Covered

Table Global Pharmacovigilance (PV) Market Size Growth Rate by

Please fill the form below, to recieve the report sample


+1